News – Page 1033 – Endpoints News

SIGN UP

In a comeback, Portola scores FDA accelerated approval for once-rejected Andexxa

8 years ago

Rejected: After paying $80M to acquire it, Mallinckrodt's jaundice drug snubbed by FDA's advisory committee

8 years ago

Sarepta’s eteplirsen spurned as European regulators turn thumbs down on controversial Duchenne MD drug

8 years ago

Merck doubles down on Moderna's mRNA cancer vaccines, paying $125M to partner on KRAS shared antigen strategy

8 years ago

After raising VC money weeks ago, Unity tacks on an $85M IPO; Abpro sets terms for $60M IPO

8 years ago

FDA motions Alnylam's lumasiran into a PhIII short track, setting up a shot at an OK in '20

8 years ago

Merck study may signal doom for a broad group of pivotal Alzheimer’s studies

8 years ago

Raising a record $668M in new fund, Foresite sets sights on a tech-driven portfolio

8 years ago

Merck’s snapshot of positive data for frontline lung cancer niche triggers a new scramble for quick Keytruda OK

8 years ago

Glass half empty: Achaogen receives split vote from FDA experts on lead antibiotic, shares plunge

8 years ago

FDA’s back-to-back punches against biosims from Celltrion, Novartis leave Roche’s big Rituxan franchise untouched

8 years ago

Third Rock sinks $59M into Casma's 'recycling' tech, with neuro on the mind

8 years ago

Pharma's broken business model — Part 2: Scraping the barrel in drug discovery

8 years ago

Achillion's CEO Milind Deshpande steps down; NeuroVision raises $11.2M for novel Alzheimer's detection tech

8 years ago

Playing the long game in I/O, J&J inks $1.04B deal to buy oncolytic virus platform biotech BeneVir

8 years ago

High cholesterol contender Esperion slips on safety concerns, stock sinks 30%

8 years ago

Iterum tests public market's appetite for anti-infectives in $92M IPO

8 years ago

Chinese investors back Refuge Bio’s $25M B round as it steers gene engineering tech to an IND

8 years ago

Out to ‘rethink the drug design process,’ AI star Daphne Koller is creating a new machine learning venture at ...

8 years ago

Kymriah wins second FDA OK, boosting hope for Novartis' low CAR-T sales

8 years ago

‘Biohacker’ Traywick dead at 28 — known for self-injecting a DIY herpes drug

8 years ago

Pfizer cuts five cancer programs; George Church engages Cellectis' TALEN tech to create virus-resistant human cells

8 years ago

Roche boosts its gene therapy game, expanding partnership with 4D Molecular Therapeutics

8 years ago

Under pressure, Peter Hecht splits Ironwood into two biotechs, spinning out an R&D operation

8 years ago

First page Previous page 1030 1031 103210331034 1035 1036 Next page Last page